20% of U.S. adults take psychiatric drugs

Nov 17 2011NewsGuard 100/100 Score

The Wall Street Journal: Psychiatric Drug Use Spreads
The medicating of Americans for mental illnesses continued to grow over the past decade, with one in five adults now taking at least one psychiatric drug such as antidepressants, antipsychotics and anti-anxiety medications, according to an analysis of pharmacy-claims data (Wang, 11/16).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , ,

Comments (0)

Suggested Reading

Antibiotic activity altered by interaction with nanoplastics, new research shows
Atlas maps plasma proteins to transform disease diagnosis and treatment
GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
Antiseizure medications in pregnancy tied to child neurodevelopment risks
Small Solutions for Big Problems in Drug Discovery and Delivery
Small brain-penetrating molecule offers hope for treating aggressive brain tumors
Squid-inspired technology could replace needles for medications and vaccines
Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Expanded access to weight-loss drugs could save thousands of lives